Obesity-Associated Hypertension

  • Kamal Rahmouni
    From the Specialized Center of Research in Hypertension Genetics, Cardiovascular Center, the Department of Internal Medicine and the General Clinical Research Center, University of Iowa, Iowa City.
  • Marcelo L.G. Correia
    From the Specialized Center of Research in Hypertension Genetics, Cardiovascular Center, the Department of Internal Medicine and the General Clinical Research Center, University of Iowa, Iowa City.
  • William G. Haynes
    From the Specialized Center of Research in Hypertension Genetics, Cardiovascular Center, the Department of Internal Medicine and the General Clinical Research Center, University of Iowa, Iowa City.
  • Allyn L. Mark
    From the Specialized Center of Research in Hypertension Genetics, Cardiovascular Center, the Department of Internal Medicine and the General Clinical Research Center, University of Iowa, Iowa City.

書誌事項

タイトル別名
  • New Insights Into Mechanisms
公開日
2005-01
DOI
  • 10.1161/01.hyp.0000151325.83008.b4
公開者
Ovid Technologies (Wolters Kluwer Health)

この論文をさがす

説明

<jats:p>Obesity is strongly associated with hypertension and cardiovascular disease. Several central and peripheral abnormalities that can explain the development or maintenance of high arterial pressure in obesity have been identified. These include activation of the sympathetic nervous system and the renin-angiotensin–aldosterone system. Obesity is also associated with endothelial dysfunction and renal functional abnormalities that may play a role in the development of hypertension. The continuing discovery of mechanisms regulating appetite and metabolism is likely to lead to new therapies for obesity-induced hypertension. Better understanding of leptin signaling in the hypothalamus and the mechanisms of leptin resistance should facilitate therapeutic approaches to reverse the phenomenon of selective leptin resistance. Other hunger and satiety signals such as ghrelin and peptide YY are potentially attractive therapeutic strategies for treatment of obesity and its complications. These recent discoveries should lead to novel strategies for treatment of obesity and hypertension.</jats:p>

収録刊行物

  • Hypertension

    Hypertension 45 (1), 9-14, 2005-01

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (13)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ